Skip to content
中文产业新闻评分64Chinese source

BioNTech BNT113头颈癌2/3期临床未达PFS主要终点

BioNTech跌7%：HPV mRNA疫苗头颈癌2/3期临床错失PFS主要终点

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.